Study summary

The purpose of this study is to evaluate the safety and efficacy of ASP015K in moderate to severe rheumatoid arthritis subjects who are methotrexate-inadequate responders (MTX-IR).

Additional Study Details

Phase
2
Product
  • peficitinib
  • Placebo
  • methotrexate
  • Type
    Interventional
    Masking
    Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
    Enrollment number
    379
    Show Additional Study Details

    Study documents

    Scientific Results Summary
    Available Language(s): English
    Plain Language Summary
    Available Language(s): English

    Get more information

    Would you like more information about clinical trial sites that are recruiting participants for A Study to Evaluate the Safety and Efficacy of ASP015K in Moderate to Severe Rheumatoid Arthritis Subjects Who Have Had an Inadequate Response to Methotrexate? Contact us by filling out your information to the right and we’ll respond to you.

    • A patient
    • A caregiver
    • A parent
    • A healthcare provider
    • A patient advocate
    • Algeria
    • Argentina
    • Armenia
    • Australia
    • Austria
    • Belarus
    • Belgium
    • Bosnia And Herzegovina
    • Brazil
    • Bulgaria
    • Canada
    • Chile
    • China
    • Colombia
    • Croatia
    • Czech Republic
    • Denmark
    • Dominican Republic
    • Egypt
    • Estonia
    • Finland
    • Former Serbia and Montenegro
    • France
    • Georgia
    • Germany
    • Greece
    • Guatemala
    • Hong Kong
    • Hungary
    • Iceland
    • India
    • Indonesia
    • Ireland
    • Israel
    • Italy
    • Japan
    • Jordan
    • Kazakhstan
    • Latvia
    • Lebanon
    • Lithuania
    • Macedonia
    • Malaysia
    • Mexico
    • Montenegro
    • Morocco
    • Netherlands
    • New Zealand
    • Norway
    • Panama
    • Peru
    • Philippines
    • Poland
    • Portugal
    • Puerto Rico
    • Republic of Korea
    • Republic of Moldova
    • Romania
    • Russian Federation
    • Saudi Arabia
    • Serbia
    • Singapore
    • Slovakia
    • Slovenia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Taiwan, Province of China
    • Thailand
    • Turkey
    • Ukraine
    • United Kingdom
    • United States
    • Vietnam

    By clicking ["Continue/Submit"], you agree that Astellas may contact you by email with information to help you connect with clinical trial sites. While we can connect you to clinical trial sites, we cannot answer questions about any investigational therapy through email. Your consent to receiving emails is not a requirement to participate in a clinical trial or study. For more information, including how to unsubscribe at any time, see our Privacy Notice & Cookies Policy.

      Locations

      Contact Us
      Contact Us
      Completed
      MHAT Burgas
      Burgas, Bulgaria, 8000
      Completed
      Health Research of Oklahoma
      Oklahoma City, OK, United States, 73103
      Completed
      Clincal Research Center of Reading
      Wyomissing, PA, United States, 19610
      Completed
      MHAT "Sv. Ivan Rilski"
      Sofia, Bulgaria, 1612
      Completed
      Zespol Poradni Specjalistycznych REUMED sp. Zo.o
      Lublin, Poland, 20-582
      Completed
      Centrum Osteoporozy i Chorob KKostno-Stawowych Daniluk Clinical Research Centre
      Bialystok, Poland, 15-461
      Completed
      NZOZ Osteo-Medic sc A. Racewicz, J. Supronik
      Bialystok, Poland, 15-351
      Completed
      University of California San Diego
      LaJolla, CA, United States, 92093-0943
      Completed
      Cliditer S.A. de C.V.Huerta S.I.
      Mexico D.F., Mexico, 6700
      Completed
      Centro Integral De Reumatologia E Inmunologia
      Bogota, Colombia
      Completed
      PMG Research
      Hickory, NC, United States, 28602
      Completed
      PV-MEDICAL s.r.o.
      Zlin, Czech Republic, 760 01
      Completed
      Centro Integral de Reumatología del Caribe S.A.S
      Barranquilla, Colombia
      Completed
      MHAT Plovdiv AD
      Plovdiv, Bulgaria, 4003
      Completed
      The Center for Rheumatology and Bone Research
      Wheaton, MD, United States, 20902
      Completed
      MEDICAL PLUS, s.r.o. or REVMACENTRUM UH, s.r.o.
      Uherske Hradiste, Czech Republic, 68601
      Completed
      Rethy Pal Korhaz es Rendelointezet
      Bekescsaba, Hungary, 5600
      Completed
      Arthritis Associates of Colorado Springs
      Colorado Springs, Colorado, United States, 80910
      Completed
      The Talbert Group
      Huntington Beach, CA, United States, 92646
      Completed
      Desert Medical Advances
      Palm Desert, CA, United States, 92260
      Completed
      Revita Clinic Rheumatology
      Budapest, Hungary, 1027
      Completed
      Achieve Clinical Research, LLC
      Birmingham, AL, United States, 35216
      Completed
      Morales Vargas Centro de Investigacion, SC Rheumatology
      Leon, Guanajuato, Mexico, 37000
      Completed
      Szpital Uniwersytecki nr. 2 im. Dr. Jana Biziela
      Bydgoszcz, Poland, 85-168
      Completed
      Center for Arthritis & Rheumatic Disease, P.C.
      Chesapeake, VA, United States, 23320
      Completed
      MEDICITY SAS
      Bucaramanga, Colombia
      Completed
      NZOZ Centrum Medyczne ProMiMed
      Krakow, Poland, 31-637
      Completed
      Illinois Bone & Joint
      Morton Grove, IL, United States, 60053
      Completed
      SERVIMED E.U.
      Bucaramanga, Colombia
      Completed
      Center for Arthritis and Osteoporosis
      Elizabethtown, KY, United States, 42701
      Completed
      Hospital Civil de Guadalajara Fray Antonio Alcalde Gutierrez
      Guadalajara, Mexico, 44280
      Completed
      Deerbrook Medical Asssociates
      Vernon Hills, IL, United States, 60061
      Completed
      Centro de medicina Interna Julian Coronel
      Cali, Colombia
      Completed
      Mountain State Clinical Research
      Clarksburg, WV, United States, 26301
      Completed
      Austin Rheumatology Research PA
      Austin, Texas, United States, 78705
      Completed
      Hospital Erasme
      Brussels, Belgium, 1070
      Completed
      IPS Rodrigo Botero SAS
      Medellin, Antioquia, Colombia, 5001000
      Completed
      Kenezy Hospital Institute of Clinical Pharmacology
      Debrecen, Hungary, H-4043
      Completed
      DRC Gyogyszervizsgalo Kozpont Kft
      Balatonfured, Hungary, H-8230
      Completed
      Pacific Arthritis Center Medical Group
      Santa Maria, California, United States, 93454
      Completed
      Arthritis Associates
      Orlando, FL, United States, 32804
      Withdrawn
      Centro Integral en Reumatologia, SA de CV
      Guadalajara, Mexico, 44158
      Completed
      Revmatologicky ustav
      Praha 2, Czech Republic, 128 50
      Completed
      Dr Javier Orozco Alcala Private Doctor´s office
      Guadalajara, Mexico, 44650
      Completed
      Rheumatology Consultants, PLLC
      Knoxville, TN, United States, 37909-1907
      Completed
      Rheuma Medicus Zaktad Opieki Zdrowotnej Relle Brkolozka
      Wraszawa, Poland, 02-118
      Completed
      ARS Rheumatica
      Warszawa, Poland, 02-653
      Completed
      Altoona Center for Clinical Research
      Duncansville, PA, United States, 16635
      Completed
      Moliere Hospital
      Brussels, Belgium, 1190
      Completed
      Centro de Investigacion Clinica de Morelia, S.C.
      Morelia, Mexico, 58070

      Frequently Asked Questions

      Are clinical trials only for people with advanced cancer?

      While some clinical trials may focus on more advanced cancers, many trials are open to patients at various stages of their cancer. Each study has rules about who can take part. For example, only patients in a certain age group or those who have a certain type of tumor may be able to join.

      Will I have to stop my current treatment to participate in a clinical trial?

      Sometimes researchers want participants to keep taking their current treatments during a clinical trial. Other times, you may need to stop your current treatments for a while. If the investigational treatment doesn't work, you can usually go back to your original treatment plan.

      Should I be worried about getting a placebo?

      In cancer clinical trials, a placebo is only used if there is no other treatment for that type of cancer. This helps compare an investigational treatment to the placebo. Placebos are rarely used in cancer trials because the best available treatment, called the “standard of care”, is usually given instead.

      Do I need a referral from my doctor to take part in a study?

      Your doctor may not know about all the opportunities for clinical trials that are available to you. Talk to your doctor or other medical provider about clinical trial information that you find. They can help you decide if a clinical trial is right for you. If you do not find any options on this website, we recommend you visit an online public registry website like clinicaltrials.gov to see a wide variety of available clinical trials.

      Explore More

      1

      What are clinical trials?

      2

      Why are Clinical Trials Important?

      3

      Why Participate in a Clinical Trial?